Answers are grounded in this paper and cite their sources.
Design blueprint derived from the source paper (DOI 10.5281/zenodo.24331574): A sensor that must detect a trace of a substance in a liquid needs to see a tiny change in refractive index, and it needs to see it quickly and without a laboratory. Operating principle: a plasmonic sensor whose resonance wavelength shifts when the refractive index of the liquid above it changes, turning a chemical change into a colour change a spectrometer can read. The sensor offers a sensitivity of 420 nanometres per refractive index unit at a resonance wavelength of 650 nanometres, with a figure of merit of 85 and a detection limit of 0.000129 refractive index units. The sensor reads a small index change as a measurable wavelength shift, which is the capability that makes it a candidate for bedside diagnostics and for environmental monitoring. SIMULATED, NOT MEASURED. This is a computed study for a civilian optics purpose: the device serves imaging, sensing, communications or illumination, and it carries no targeting or weapon application against any person, state or terrestrial object. Status: DESIGN BLUEPRINT — SIMULATED, NOT MEASURED — NOT BUILT. All numbers are simulated values from the source paper's computation, deposited with this blueprint as compute.py and results.json. The design is a civilian metamaterial optical device for imaging, sensing, communications or illumination, and has no targeting or weapon application. AI-use disclosure: Dave, an AI research system, assisted with the computation and drafting under the author's direction; author of record William Alexander Aldred.
No takes yet. Share an insight, caveat, or question.
William Alexander Aldred (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: